The Cancer Letter

Inside information on cancer research and drug development

Vol.
26
No.
13
March 31, 2000Mar 31, 2000
Free
DOWNLOAD THE PDF

Advisors Approve NCI Plan To Contract For Early Clinical Trials Of Imaging Agents.

NCI Recruits Carl Barrett Of NIEHS To Direct Basic Sciences; Freedman named to NCAB.

Sieber Direct Communications At NCI, Reorganizing Offices.

“5 A Day” Review Underway to Check Program’s Health at NCI.

AACR Honors Nine Cancer Researchers, Clinicians.

Cytogen Corp.’s Imaging Agent ProstaScint Added to NCCN Prostate Cancer Guidelines.

FDA Grants Six-Month Priority Review To Nolvadex For DCIS Adjuvant Treatment.

Bristol-Myers, Karolinska In Collaboration For Studies.

Antigenics Begins Phase II Trial Of Oncophage for NHL.

Aphton To Test Anti-Gastrin Drug At M. D. Anderson. NAS

RFP: Intellectual Property.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account